Candel Therapeutics Inc (NASDAQ:CADL), Inc announced that its CEO Paul Peter Tak will participate in upcoming investor conferences with associated one-on-one investor meetings.
The clinical-stage biopharmaceutical company said Tak will be involved with Citi's 2025 Biopharma Back to School Conference on September 3, Cantor Global Healthcare Conference on September 4, and H.C. Wainwright 27th Annual Global Investment Conference on September 5.
Live webcasts of the presentations will be available by selecting Events and Presentations under the News & Events tab on the company's website.